Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases
Abstract Background Dyspnoea is a disabling symptom in patients admitted with heart failure (HF) and respiratory diseases (RD). The main aim of this study is to evaluate its intensity at admission and discharge and the relation with quality of life. We also describe its management, intensity, and ev...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | BMC Palliative Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12904-017-0208-x |
id |
doaj-258a2c787b0f47aaa8763c158d193816 |
---|---|
record_format |
Article |
spelling |
doaj-258a2c787b0f47aaa8763c158d1938162020-11-24T21:54:00ZengBMCBMC Palliative Care1472-684X2017-05-011611910.1186/s12904-017-0208-xDegree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseasesLourdes Vicent0Juan Manuel Nuñez Olarte1Luis Puente-Maestu2Alicia Oliva3Juan Carlos López4Andrea Postigo5Irene Martín6Raquel Luna7Francisco Fernández-Avilés8Manuel Martínez-Sellés9Department of Cardiology, Hospital General Universitario Gregorio MarañónDepartment of Palliative Care, Hospital General Universitario Gregorio MarañónUniversidad ComplutenseDepartment of Respiratory Medicine, University Hospital Gregorio MarañónDepartment of Cardiology, Hospital General Universitario Gregorio MarañónDepartment of Cardiology, Hospital General Universitario Gregorio MarañónDepartment of Cardiology, Hospital General Universitario Gregorio MarañónDepartment of Cardiology, Hospital General Universitario Gregorio MarañónDepartment of Cardiology, Hospital General Universitario Gregorio MarañónDepartment of Cardiology, Hospital General Universitario Gregorio MarañónAbstract Background Dyspnoea is a disabling symptom in patients admitted with heart failure (HF) and respiratory diseases (RD). The main aim of this study is to evaluate its intensity at admission and discharge and the relation with quality of life. We also describe its management, intensity, and evolution in HF and RD. Methods In this descriptive, cross-sectional study, we included prospectively all patients admitted with decompensated HF and chronic obstructive pulmonary disease (COPD)/pulmonary fibrosis during 4 months. Surveys quantifying dyspnoea (Numerical Rating Scale 1-10) and quality of life (EuroQoL 5d) were administered at discharge. Results A total of 258 patients were included: 190 (73.6%) with HF and 68 (26.4%) with RD (62 COPD and 6 pulmonary fibrosis). Mean age was 74.0±1.2 years, and 157 (60.6%) were men. Dyspnoea before admission was 7.5±0.1. Patients with RD showed greater dyspnoea than those with HF both before admission (8.1±0.2 vs. 7.3±0.2, p=0.01) and at discharge (3.2±0.3 vs. 2.0±0.2, p=0.0001). They also presented a higher rate of severe dyspnoea (≥5) at discharge (23 [34.3%] vs. 36 [19.1%], p=0.02). Opioids were used in 41 (15.9%), mean dose 8.7±0.8 mg Morphine Equivalent Daily Dose. HF patients had worse EuroQoL 5d scores than those with RD, due to mobility problems (118 [62.1%] vs. 28 [41.8%], p=0.004), and lower punctuation in Visual Analogue Scale (57.9±1.6 vs. 65.6±1.0, p=0.006). Conclusions About a quarter of patients admitted with HF or RD persist with severe dyspnoea at discharge. Opioids are probably underused. HF patients have less dyspnoea than patients with RD but present worse quality of life.http://link.springer.com/article/10.1186/s12904-017-0208-xDyspnoeaHeart failureChronic obstructive pulmonary diseaseMorphineEuroQoL 5d |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lourdes Vicent Juan Manuel Nuñez Olarte Luis Puente-Maestu Alicia Oliva Juan Carlos López Andrea Postigo Irene Martín Raquel Luna Francisco Fernández-Avilés Manuel Martínez-Sellés |
spellingShingle |
Lourdes Vicent Juan Manuel Nuñez Olarte Luis Puente-Maestu Alicia Oliva Juan Carlos López Andrea Postigo Irene Martín Raquel Luna Francisco Fernández-Avilés Manuel Martínez-Sellés Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases BMC Palliative Care Dyspnoea Heart failure Chronic obstructive pulmonary disease Morphine EuroQoL 5d |
author_facet |
Lourdes Vicent Juan Manuel Nuñez Olarte Luis Puente-Maestu Alicia Oliva Juan Carlos López Andrea Postigo Irene Martín Raquel Luna Francisco Fernández-Avilés Manuel Martínez-Sellés |
author_sort |
Lourdes Vicent |
title |
Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases |
title_short |
Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases |
title_full |
Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases |
title_fullStr |
Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases |
title_full_unstemmed |
Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases |
title_sort |
degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases |
publisher |
BMC |
series |
BMC Palliative Care |
issn |
1472-684X |
publishDate |
2017-05-01 |
description |
Abstract Background Dyspnoea is a disabling symptom in patients admitted with heart failure (HF) and respiratory diseases (RD). The main aim of this study is to evaluate its intensity at admission and discharge and the relation with quality of life. We also describe its management, intensity, and evolution in HF and RD. Methods In this descriptive, cross-sectional study, we included prospectively all patients admitted with decompensated HF and chronic obstructive pulmonary disease (COPD)/pulmonary fibrosis during 4 months. Surveys quantifying dyspnoea (Numerical Rating Scale 1-10) and quality of life (EuroQoL 5d) were administered at discharge. Results A total of 258 patients were included: 190 (73.6%) with HF and 68 (26.4%) with RD (62 COPD and 6 pulmonary fibrosis). Mean age was 74.0±1.2 years, and 157 (60.6%) were men. Dyspnoea before admission was 7.5±0.1. Patients with RD showed greater dyspnoea than those with HF both before admission (8.1±0.2 vs. 7.3±0.2, p=0.01) and at discharge (3.2±0.3 vs. 2.0±0.2, p=0.0001). They also presented a higher rate of severe dyspnoea (≥5) at discharge (23 [34.3%] vs. 36 [19.1%], p=0.02). Opioids were used in 41 (15.9%), mean dose 8.7±0.8 mg Morphine Equivalent Daily Dose. HF patients had worse EuroQoL 5d scores than those with RD, due to mobility problems (118 [62.1%] vs. 28 [41.8%], p=0.004), and lower punctuation in Visual Analogue Scale (57.9±1.6 vs. 65.6±1.0, p=0.006). Conclusions About a quarter of patients admitted with HF or RD persist with severe dyspnoea at discharge. Opioids are probably underused. HF patients have less dyspnoea than patients with RD but present worse quality of life. |
topic |
Dyspnoea Heart failure Chronic obstructive pulmonary disease Morphine EuroQoL 5d |
url |
http://link.springer.com/article/10.1186/s12904-017-0208-x |
work_keys_str_mv |
AT lourdesvicent degreeofdyspnoeaatadmissionanddischargeinpatientswithheartfailureandrespiratorydiseases AT juanmanuelnunezolarte degreeofdyspnoeaatadmissionanddischargeinpatientswithheartfailureandrespiratorydiseases AT luispuentemaestu degreeofdyspnoeaatadmissionanddischargeinpatientswithheartfailureandrespiratorydiseases AT aliciaoliva degreeofdyspnoeaatadmissionanddischargeinpatientswithheartfailureandrespiratorydiseases AT juancarloslopez degreeofdyspnoeaatadmissionanddischargeinpatientswithheartfailureandrespiratorydiseases AT andreapostigo degreeofdyspnoeaatadmissionanddischargeinpatientswithheartfailureandrespiratorydiseases AT irenemartin degreeofdyspnoeaatadmissionanddischargeinpatientswithheartfailureandrespiratorydiseases AT raquelluna degreeofdyspnoeaatadmissionanddischargeinpatientswithheartfailureandrespiratorydiseases AT franciscofernandezaviles degreeofdyspnoeaatadmissionanddischargeinpatientswithheartfailureandrespiratorydiseases AT manuelmartinezselles degreeofdyspnoeaatadmissionanddischargeinpatientswithheartfailureandrespiratorydiseases |
_version_ |
1725869511442169856 |